Endpoint Clinical appoints Bryan Clayton as Chief Commercial Officer

Endpoint’ers welcome Bryan Clayton as Chief Commercial Officer!

Bryan comes to Endpoint as a seasoned global commercial leader with experience across multiple functions including sales and marketing, operations, and software product design. In his new role, he will drive Endpoint’s Business Development and Commercial Strategy efforts, including sales strategy development and execution, commercial strategy, and marketing.

“Being in the clinical trial industry since 2010, I have watched Endpoint Clinical grow from a small tech operation fighting for a ‘seat at the table’ to one of the global leaders in IRT and supporting technologies,” says Clayton. “The industry demands a flexible, reliable, and patient-centric approach and Endpoint Clinical has the partnerships and experience to deliver. That’s why I am thrilled to join Endpoint to lead their commercial strategy and business development operations and to further strengthen their expertise in providing agile, patient-centric IRT solutions paired with exceptional service.”

Bryan has effectively managed cross-functional teams, created new technology solutions, managed contract negotiations, and driven revenue growth for several top life sciences technology providers. He is a sought-after speaker, writer, and contributor to industry events and publications, and possesses a range of skills well-suited to boost commercial success and revenue growth. We are happy to have him join the global Endpoint Clinical team!

Read more about Endpoint’s solutions at https://www.endpointclinical.com/solutions/